biote Corp.
BTMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.30 | -2.04 | -0.19 | -0.02 |
| FCF Yield | 18.33% | 19.03% | -36.58% | 40.30% |
| EV / EBITDA | 18.17 | 16.56 | 7.71 | 2.36 |
| Quality | ||||
| ROIC | 1.84% | 468.00% | -47.22% | 81.06% |
| Gross Margin | 70.52% | 68.78% | 66.92% | 64.98% |
| Cash Conversion Ratio | 983.54 | 8.11 | -6.92 | 1.03 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.13% | 9.97% | 12.27% | 8.22% |
| Free Cash Flow Growth | 60.58% | 319.83% | -136.76% | 19.50% |
| Safety | ||||
| Net Debt / EBITDA | 4.59 | 2.80 | 4.46 | 0.29 |
| Interest Coverage | 2.87 | 4.50 | -15.00 | 20.66 |
| Efficiency | ||||
| Inventory Turnover | 3.92 | 2.76 | 4.88 | 5.08 |
| Cash Conversion Cycle | 70.97 | 121.98 | 62.66 | 53.07 |